Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Glenmark Life Sciences IPO.
July 21, 2021 5:59:00 PM
Glenmark Life Sciences, subsidiary of Glenmark Pharmaceuticals is all set to raise ?1,060 crore through its IPO. The IPO will open for subscription on July 27 and close on July 29 with a price ...
Published by : Business Insider IndiaAugust 6, 2021 9:18:00 AM
Shares of Glenmark Life Sciences list at over 4% premium from its price band of ?695-720 per share. The IPO was subscribed 45.08 times on the last day of the bidding. The market capitalisation ...
Published by : Business Insider IndiaJuly 20, 2021 1:07:00 PM
Glenmark Life Sciences' IPO timing is opportune, but it needs to strike deep relationships with global innovators and attain market leadership in key products Glenmark Pharma’s API arm Glenmark ...
Published by : moneycontrol.comFebruary 17, 2024 3:30:00 AM
Glenmark Life Sciences Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) ...
Published by : money.rediffJuly 10, 2024 3:12:00 PM
Glenmark Pharma said on July 10 that its board approved selling 7.84 percent stake in Glenmark Life Sciences through an offer for sale. "We wish to inform you that the Board of Directors, at its ...
Published by : MSNOctober 24, 2024 5:30:00 PM
Glenmark Life Sciences Ltd (BOM:543322) is set to release its Q2 2025 earnings on Oct 25, 2024. The consensus estimate for Q2 2025 revenue is $5.78 billion, and the earnings are expected to come ...
Published by : Yahoo FinanceOctober 24, 2024 7:03:00 PM
Oct 24 (Reuters) - Indian drugmaker Glenmark Life Sciences (GLEM.NS), opens new tab posted a fall in second-quarter profit on Thursday, hurt by the temporary closure of a manufacturing facility in ...
Published by : ReutersOctober 31, 2024 4:30:00 AM
Here's the list of Glenmark Life's futures contracts. The future contract comprises financial derivative contracts that bind parties to buy and sell an asset at a specified future timeand price.
Published by : India InfolineJuly 25, 2023 3:55:00 AM
India's Glenmark Life Sciences Q3 profit rises 1 per cent on API strength The Mumbai-based drug maker's profit rose to 1.05 billion rupees ($12.86 million) in the three months ended Dec 31 ...
Published by : health.economictimes.indiatimesOctober 25, 2024 4:57:00 PM
Glenmark Life Sciences‘ net profit for the second quarter of fiscal year 2025 fell 20% year-on-year (YoY) to ?95.32 Crore. This is due to the temporary closure of its Gujarat manufacturing site.
Published by : India InfolineOctober 31, 2024 4:30:00 AM
Glenmark Life Sciences Ltd share price was up by 0.00% from the previous closing price of ?1,057.20. Who are peers of Glenmark Life Sciences Ltd? The peers of Glenmark Life Sciences Ltd are Sun ...
Published by : Business TodayThe IPO Shares of Glenmark Life Sciences Limited IPO are proposed to list on Friday, August 6, 2021 at BSE, NSE. The public issue of Glenmark Life Sciences IPO was opened on Jul 27, 2021 and closed for subscription on Jul 29, 2021. Glenmark Life Sciences IPO Listing Date and Information:
| Listing Date | Friday, August 6, 2021 |
| BSE Script Code | 543322 |
| NSE Symbol | GLS |
| Listing In | B Group of Securities |
| ISIN | INE03Q201024 |
| Issue Price | ₹720 Per Equity Share |
| Face Value | ₹2 Per Equity Share |
The allotment status of Glenmark Life Sciences Limited IPO is now available online. The public issue of Glenmark Life Sciences IPO was open on Jul 27, 2021 and closed for subscription on Jul 29, 2021. The equity shares of the company to be list at BSE, NSE
.
Glenmark Life Sciences Limited is entering in the capital market with an IPO of [.] Equity Shares of Rs 2 aggregating up to Rs [.] Crore. The price for the issue has been set at Rs - Rs Per Equity Share.
Incorporated in 2011, Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies.
The issue opens on Jul 27, 2021 and closes for subscription on Jul 29, 2021. The equity shares of the company to be list at BSE, NSE.
The issue of Glenmark Life Sciences Limited opens on Jul 27, 2021 and closes for subscription on Jul 29, 2021. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs - Rs Per Equity Share.
The Glenmark Life Sciences IPO is proposed to open on July 27, 2021. The IPO application ends on July 29, 2021.
Retail investors can apply in the retail or non-institutional investor category from July 27, 2021 to July 29, 2021. The Glenmark Life Sciences IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Glenmark Life Sciences IPO will open for subscription on July 27, 2021. The public issue will close on July 29, 2021.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
